Web Notifications

SaltWire.com would like to send you notifications for breaking news alerts.

Activate notifications?

P.E.I. supports new jobs at cannabis processing facility

In an emailed response from the Department of Justice and Public Safety, the department confirmed that an oral fluid drug testing device for cannabis has been approved by the federal government and they are awaiting its deployment in the province. The Canadian government approved of this device in September last year, but the department did not give a timeline for when these devices will be used in Newfoundland and Labrador.
Cannabis leaf. - -File photo

STORY CONTINUES BELOW THESE SALTWIRE VIDEOS

Olive Tapenade & Vinho Verde | SaltWire

Watch on YouTube: "Olive Tapenade & Vinho Verde | SaltWire"

The provincial government will support 32 new jobs at Dosecann, a cannabis oil extraction company in the Biocommons Industrial Park in Charlottetown.

Dosecann is a Health Canada approved and licensed cannabis processor. Its 42,000 square foot, purpose-built analytical testing facility in Charlottetown serves as the hub for Dosecann’s cannabis extraction, product innovation and formulation, research and development, quality testing and manufacturing.

To assist the company and support 32 new jobs, the province is providing labour rebates worth a maximum of $716,000 over two years. The province is also providing $60,000 to assist the company with rental costs.

Across Canada companies are preparing to meet current and future demand for cannabis products. With additional products scheduled to enter the medical and recreational markets later this year, many companies will soon be executing their plans.

Dosecann - a subsidiary of vertically integrated cannabis company Auxly Cannabis Group Inc. - is developing consumer centric products by undertaking supercritical CO2 extraction to separate cannabis oil for medical and recreational consumer products.

Dosecann products will span all three broad classes of products, including edible cannabis, cannabis extracts and topical products. The company’s products will be sold to provincial purchasers for distribution through provincial retail channels for adult recreational use and directly to patients for medical use.

Share story:
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT